Litcius/Paper detail

Synthesis of Chiral Hydantoins and Thiazolidinediones <i>via</i><scp>Iridium‐Catalyzed</scp> Asymmetric Hydrogenation

Yu Nie, Jing Li, Qianjia Yuan, Wanbin Zhang

2022Chinese Journal of Chemistry25 citationsDOI

Abstract

Comprehensive Summary Herein, we report an iridium‐catalyzed asymmetric hydrogenation of hydantoin and thiazolidinedione derived exocyclic alkenes using our developed BiphPHOX as a ligand. The transformation shows good functional group tolerance, and gives the hydrogenated products with excellent yields (up to 99%) and enantioselectivities (up to 98% ee). A gram‐scale reaction was also carried out, and provided the hydrogenated product in excellent yield with no erosion in enantioselectivity. Finally, the transformation of the hydrogenated product provided an efficient approach for the synthesis of the intermediate of a HIV protease inhibitor.

Topics & Concepts

ChemistryIridiumAsymmetric hydrogenationHydantoinCatalysisYield (engineering)Combinatorial chemistryLigand (biochemistry)Enantioselective synthesisTransformation (genetics)Organic chemistryMedicinal chemistryReceptorMaterials scienceBiochemistryGeneMetallurgyAsymmetric Hydrogenation and CatalysisSurface Chemistry and CatalysisHIV/AIDS drug development and treatment
Synthesis of Chiral Hydantoins and Thiazolidinediones <i>via</i><scp>Iridium‐Catalyzed</scp> Asymmetric Hydrogenation | Litcius